openPR Logo
Press release

Food Allergy Pipeline Insight Report 2023 (Updated) | Companies - Merck & Co, DBV technologies, Genentech, Camallergy, Regeneron Pharmaceuticals, InnoUp Farma, Aravax, Novartis, and Others

08-11-2023 02:38 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Food Allergy Pipeline

Food Allergy Pipeline

DelveInsight's report titled "Food Allergy Pipeline Insight, 2023" offers extensive information on more than 30+ companies and over 35+ pipeline drugs in the field of Food Allergy research. The report encompasses detailed profiles of the Food Allergy pipeline drugs, including information on clinical trials and nonclinical stage products. It also provides a comprehensive assessment of the therapeutics based on product type, stage, route of administration, and molecule type. Additionally, the report highlights the inactive pipeline products in this domain.

The research on the Food Allergy pipeline covers various aspects such as business opportunities, challenges, potential partnerships, strong competitors, and growth strategies. It provides a detailed description of each drug, including its mechanism of action, clinical trial studies conducted for Food Allergy, any NDA approvals obtained for Food Allergy, and the product development activities encompassing technology, collaborations, licensing, mergers and acquisitions, funding, designations, and other relevant details.

To explore more information on the latest breakthroughs in the Food Allergy Pipeline treatment landscape of the report, click here @ Food Allergy Pipeline Outlook- https://www.delveinsight.com/report-store/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Food Allergy Pipeline Report
• DelveInsight's Food Allergy pipeline analysis depicts a robust space with 30+ active players working to develop 35+ Food Allergy pipeline treatment therapies.
• The leading Food Allergy companies proactively working to develop potential drug candidates to improve the Food Allergy treatment options include Merck & Co, AstraZeneca, Mabylon, GI Innovation, Aimmune Therapeutics, Inc, Novartis Pharmaceuticals, DBV Technologies, InnoUp Farma S.L., COUR Pharmaceutical Development Company Inc, Vedanta Biosciences, Inc, Regeneron Pharmaceuticals, Genentech, Inc, Camallergy, Aravax, Inimmune, Prota therapeutics, Intrommune Therapeutics, Alladapt Immunotherapeutics, Siolta Therapeutics, IgGenix, Rho Federal Systems Division, Inc, and many others.
• Promising Food Allergy pipeline therapies such as Viaskin Peanut/DBV712, CA002, Omalizumab, Ligelizumab, Dupixent, Viaskin Milk, ADP101, PVX108, INT 301, PRT100, STMC-103H, AR601, and others are under development in different phases of clinical trials.
• In March 2022, Aravax, announced that it had received a green light for its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA). PVX108 is a next-generation, allergen-specific immunotherapy using peptides that represent critical fragments of peanut proteins to precisely target the T cells driving peanut allergy.
• In January 2022, Alladapt Immunotherapeutics Inc., announced the completion of patient enrollment in Harmony, its Phase 1/2 study of ADP101 for the treatment of food allergy (FA).DP101, the Company's lead program, is a potentially best-in-class oral immunotherapy (OIT) designed to desensitize patients allergic to one or multiple foods simultaneously to mitigate the risk of severe, life-threatening allergic reactions.

Food Allergy Overview
A food allergy occurs when the body's immune system sees a certain food as harmful and reacts by causing symptoms. This is an allergic reaction. Foods that cause allergic reactions are allergens. The results of skin prick tests (SPT), IgE total and specific antibodies, and patient histories are not predictive of true food allergy, as they are not able to establish the causal and temporal relationship between the intake of the suspect food and the hypersensitivity reaction.

For further information, refer to the detailed Food Allergy Unmet Needs, Food Allergy Market Drivers, and Food Allergy Market Barriers, click here for Food Allergy Ongoing Clinical Trial Analysis- https://www.delveinsight.com/sample-request/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Food Allergy Emerging Drugs Profile
• Viaskin Peanut: DBV technologies
• Omalizumab: Genentech
• Dupilumab: Regeneron Pharmaceuticals
• ADP101: Alladapt Immunotherapeutics

Food Allergy Pipeline Therapeutics Assessment
There are approx. 30+ Food Allergy companies which are developing the Food Allergy therapies. The companies which have their Food Allergies drug candidates in the most advanced stage, i.e. preregistration include, DBV technologies.

Request a sample and discover the recent advances in Food Allergy Ongoing Clinical Trial Analysis and Medications, click here @ Food Allergy Treatment Landscape- https://www.delveinsight.com/sample-request/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Food Allergy Pipeline Therapeutics Assessment
• Food Allergy Assessment by Product Type
• Food Allergy by Stage and Product Type
• Food Allergy Assessment by Route of Administration
• Food Allergy by Stage and Route of Administration
• Food Allergy Assessment by Molecule Type
• Food Allergy by Stage and Molecule Type

Some of the Companies in the Food Allergy Therapeutics Market include-
Merck & Co, AstraZeneca, Mabylon, GI Innovation, Aimmune Therapeutics, Inc, Novartis Pharmaceuticals, DBV Technologies, InnoUp Farma S.L., COUR Pharmaceutical Development Company Inc, Vedanta Biosciences, Inc, Regeneron Pharmaceuticals, Genentech, Inc, Camallergy, Aravax, Inimmune, Prota therapeutics, Intrommune Therapeutics, Alladapt Immunotherapeutics, Siolta Therapeutics, IgGenix, Rho Federal Systems Division, Inc, and many others.

Dive deep into rich insights for drugs for Food Allergy Pipeline, click here @ Food Allergy Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Food Allergy Pipeline Report
• Coverage- Global
• Food Allergy Companies- Merck & Co, AstraZeneca, Mabylon, GI Innovation, Aimmune Therapeutics, Inc, Novartis Pharmaceuticals, DBV Technologies, InnoUp Farma S.L., COUR Pharmaceutical Development Company Inc, Vedanta Biosciences, Inc, Regeneron Pharmaceuticals, Genentech, Inc, Camallergy, Aravax, Inimmune, Prota therapeutics, Intrommune Therapeutics, Alladapt Immunotherapeutics, Siolta Therapeutics, IgGenix, Rho Federal Systems Division, Inc, and others.
• Food Allergy Pipeline Therapies- Viaskin Peanut/DBV712, CA002, Omalizumab, Ligelizumab, Dupixent, Viaskin Milk, ADP101, PVX108, INT 301, PRT100, STMC-103H, AR601, and others.
• Food Allergy Pipeline Segmentation: Product Type, Molecule Type, Mechanism of Action, Route of Administration

Got Queries? Find out the related information on Food Allergy Mergers and acquisitions, Food Allergy Licensing Activities @ Food Allergy Emerging Drugs, and Recent Trends- https://www.delveinsight.com/sample-request/food-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Food Allergy Executive Summary
3. Food Allergies: Overview
4. Food Allergy Pipeline Therapeutics
5. Food Allergy Therapeutic Assessment
6. Food Allergies - DelveInsight's Analytical Perspective
7. Late Stage Products (Preregistration)
8. Viaskin Peanut: DBV technologies
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Dupilumab: Regeneron
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I/II)
14. ADP101: Alladapt Immunotherapeutics
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Research programme : antiallergy therapeutics: IgGenix
18. Food Allergy Drug profiles in the detailed report…..
19. Inactive Products
20. Food Allergies Key Companies
21. Food Allergies Key Products
22. Food Allergies- Unmet Needs
23. Food Allergies- Market Drivers and Barriers
24. Food Allergies- Future Perspectives and Conclusion
25. Food Allergies Analyst Views
26. Food Allergies Key Companies
27. Appendix

About Us

DelveInsight is a leading healthcare focussed market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Food Allergy Pipeline Insight Report 2023 (Updated) | Companies - Merck & Co, DBV technologies, Genentech, Camallergy, Regeneron Pharmaceuticals, InnoUp Farma, Aravax, Novartis, and Others here

News-ID: 3162944 • Views:

More Releases from DelveInsight Business Research

Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of 13.30% by 2032, Evaluates DelveInsight
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR of 5.50% by 2032, Evaluates DelveInsight
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR of 6.65% by 2032, Evaluates DelveInsight
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of 6.86% by 2032, Evaluates DelveInsight
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts. DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides

All 5 Releases


More Releases for Food

Food Ultrasound Market Food Ultrasound Market
According to a new report by InsightAce Analytic, the "Food Ultrasound Market" in terms of revenue was estimated to be worth $156.24 Mn in 2023 and is poised to reach $310.45 Mn by 2031, growing at a CAGR of 9.14% from 2024 to 2031. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1551 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Food Ultrasound Market are: • Food Safety and Quality Assurance. • Increasing Consumer
Prepared Food Market To Witness Huge Growth By 2028 | HSL Food, HelloFresh, Syne …
The Latest survey report on Prepared Food Market sheds lights on changing dynamics in Food & Beverages Sector and elaborates market size and growth pattern of each of Prepared Food segments. As the shift to value continues, the producers are tackling challenges to personalized nutrition and match taste profiles. A wide list of manufactuerers were considered in the survey; to include mix bag of leaders and emerging manufacturers for company
Cookies for Food Services Market Is Booming Worldwide | Finsbury Food Group, Mon …
Cookies for Food Services Market: The extensive research on Cookies for Food Services Market, by Qurate Research is a clear representation on all the essential factors that are expected to drive the market considerably. Thorough study on Cookies for Food Services Market helps the buyers of the report, customers, the stakeholders, business owners, and stockholders to understand the market in detail. The updated research report comprises key information on the
Global Sports Food Market By Type (Protein Sports Food, Energy Sports Food, Misc …
The Global Sports Food Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Sports Food Market report aims to provide an overview of Sports Food Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Sports Food Market Economy
Global Packed Food Market 2018 Analysis By Key Players – JBS Food, Kraft Food, …
Summary WiseGuyReports.com adds “Packed Food Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database. This report provides in depth study of “Packed Food Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Packed Food Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as
Pet Food Market (By Food Type, By Animal Type, By Region, By Country) of Food Ty …
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global pet food market on the basis of Food Type (Dry, Wet, Snacks, Mixers); Animal Type (Dog Food, Cat Food, Fish Food, Others), By Region (North America, Europe, APAC, ROW) and By Country (U.S.A, Canada, UK, Germany, Japan, India, China, France). Global Pet Food